CoChat

Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial

Open access
Arima, Hisatomi, Tzourio, Christophe, Butcher, Ken, Anderson, Craig, Bousser, Marie-Germaine, Lees, Kennedy R., Reid, John L., Omae, Teruo, Woodward, Mark, MacMahon, Stephen, Chalmers, John · 2006 · Stroke
Cited by 65

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background and Purpose— The relationship between baseline and recurrent vascular events may be important in the targeting of secondary prevention strategies. We examined the relationship between initial event and various types of further vascular outcomes and associated effects of blood pressure (BP)–lowering. Methods— Subsidiary analyses of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) trial, a randomized, placebo-controlled trial that established the benefits of BP–lowering in 6105 patients (mean age 64 years, 30% female) with cerebrovascular disease, randomly assigned to either active treatment (perindopril for all, plus indapamide in those with neither an indication for, nor a contraindication to, a diuretic) or placebo(s). Results— Stroke subtypes and coronary events were associated with 1.5- to 6.6-fold greater risk of recurrence of the same event (hazard ratios, 1.51 to 6.64; P =0.1 for large artery infarction, P <0.0001 for other events). However, 46% to 92% of further vascular outcomes were not of the same type. Active treatment produced comparable reductions in the risk of vascular outcomes among patients with a broad range of vascular events at entry (relative risk reduction, 25%; P <0.0001 for ischemic stroke; 42%, P =0.0006 for hemorrhagic stroke; 17%, P =0.3 for coronary events; P homogeneity=0.4). Conclusions— Patients with previous vascular events are at high risk of recurrences of the same event. However, because they are also at risk of other vascular outcomes, a broad range of secondary prevention strategies is necessary for their treatment. BP–lowering is likely to be one of the most effective and generalizable strategies across a variety of major vascular events including stroke and myocardial infarction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.str.0000221212.36860.c9

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 65

Metadata

Authors
Arima, H., Tzourio, C., Butcher, K., Anderson, C., Bousser, M.-G., Lees, K. R., Reid, J. L., Omae, T., Woodward, M., MacMahon, S., & Chalmers, J.
Venue
Stroke
Published
2006-06
Volume
37
Issue
6
Pages
1497-1502
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2127824679
Cited by
65
References
4
FWCI
2.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial. https://app.cochat.ai/papers/10.1161/01.str.0000221212.36860.c9
The paper
Arima, H., Tzourio, C., Butcher, K., Anderson, C., Bousser, M.-G., Lees, K. R., Reid, J. L., Omae, T., Woodward, M., MacMahon, S., & Chalmers, J. (2006). Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial. Stroke. https://doi.org/10.1161/01.str.0000221212.36860.c9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.